Lack of Activation Marker Induction and Chemokine Receptor Switch in Human Neonatal Myeloid Dendritic Cells in Response to Human Respiratory Syncytial Virus
暂无分享,去创建一个
R. Rabin | P. Collins | U. Buchholz | C. Le Nouën | P. Hillyer | E. Levenson | C. Martens
[1] B. Kampmann,et al. Vaccine responses in newborns , 2017, Seminars in Immunopathology.
[2] M. Heim,et al. SOCS1 is an inducible negative regulator of interferon λ (IFN-λ)–induced gene expression in vivo , 2017, The Journal of Biological Chemistry.
[3] J. Schwarze,et al. Differential lower airway dendritic cell patterns may reveal distinct endotypes of RSV bronchiolitis , 2016, Thorax.
[4] R. Garofalo,et al. Differential response of BDCA-1+ and BDCA-3+ myeloid dendritic cells to respiratory syncytial virus infection , 2013, Respiratory Research.
[5] R. Rabin,et al. Expression profiles of human interferon-alpha and interferon-lambda subtypes are ligand- and cell-dependent , 2012, Immunology and cell biology.
[6] R. Rabin,et al. Low CCR7-Mediated Migration of Human Monocyte Derived Dendritic Cells in Response to Human Respiratory Syncytial Virus and Human Metapneumovirus , 2011, PLoS pathogens.
[7] B. Graham,et al. Primary Human mDC1, mDC2, and pDC Dendritic Cells Are Differentially Infected and Activated by Respiratory Syncytial Virus , 2011, PloS one.
[8] R. Rabin,et al. Effects of Human Respiratory Syncytial Virus, Metapneumovirus, Parainfluenza Virus 3 and Influenza Virus on CD4+ T Cell Activation by Dendritic Cells , 2010, PloS one.
[9] J. Crowe,et al. Transforming Growth Factor Beta Is a Major Regulator of Human Neonatal Immune Responses following Respiratory Syncytial Virus Infection , 2010, Journal of Virology.
[10] K. Poehling,et al. The burden of respiratory syncytial virus infection in young children. , 2009, The New England journal of medicine.
[11] S. Self,et al. Neonatal Innate TLR-Mediated Responses Are Distinct from Those of Adults1 , 2009, The Journal of Immunology.
[12] R. Rabin,et al. Infection and maturation of monocyte-derived human dendritic cells by human respiratory syncytial virus, human metapneumovirus, and human parainfluenza virus type 3. , 2009, Virology.
[13] M. Suter,et al. Phenotype and function of neonatal DC , 2009, European journal of immunology.
[14] U. V. von Andrian,et al. Mechanisms and consequences of dendritic cell migration. , 2008, Immunity.
[15] P. Collins,et al. Nonstructural Proteins 1 and 2 of Respiratory Syncytial Virus Suppress Maturation of Human Dendritic Cells , 2008, Journal of Virology.
[16] Antal Rot,et al. CCR7 and its ligands: balancing immunity and tolerance , 2008, Nature Reviews Immunology.
[17] B. Graham,et al. Viral and Host Factors in Human Respiratory Syncytial Virus Pathogenesis , 2007, Journal of Virology.
[18] C. Chougnet,et al. Defective antigen-presenting cell function in human neonates. , 2006, Clinical immunology.
[19] C. Sousa,et al. Dendritic cells in a mature age , 2006, Nature Reviews Immunology.
[20] S. Deaglio,et al. CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells. , 2006, Blood.
[21] J. Banchereau,et al. Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections. , 2005, The Journal of infectious diseases.
[22] Keiji Fukuda,et al. Influenza-associated hospitalizations in the United States. , 2004, JAMA.
[23] B. Murphy,et al. Recovery of human metapneumovirus from cDNA: optimization of growth in vitro and expression of additional genes. , 2004, Virology.
[24] T. Rothoeft,et al. Respiratory syncytial virus decreases the capacity of myeloid dendritic cells to induce interferon‐γ in naïve T cells , 2003 .
[25] Keiji Fukuda,et al. Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.
[26] U. Schauer,et al. Respiratory syncytial virus induces prostaglandin E2, IL‐10 and IL‐11 generation in antigen presenting cells , 2002, Clinical and experimental immunology.
[27] R. Chanock,et al. Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial viruses. , 1988, Virus research.
[28] R. Karron,et al. Respiratory syncytial virus and metapneumovirus , 2007 .
[29] R B Couch,et al. Immunity to influenza in man. , 1983, Annual review of microbiology.